Abstract

Human DNA topoisomerase I plays a dual role in transcription, by controlling DNA supercoiling and by acting as a specific kinase for the SR-protein family of splicing factors. The two activities are mutually exclusive, but the identity of the molecular switch is unknown. Here we identify poly(ADP-ribose) as a physiological regulator of the two topoisomerase I functions. We found that, in the presence of both DNA and the alternative splicing factor/splicing factor 2 (ASF/SF2, a prototypical SR-protein), poly(ADP-ribose) affected topoisomerase I substrate selection and gradually shifted enzyme activity from protein phosphorylation to DNA cleavage. A likely mechanistic explanation was offered by the discovery that poly(ADP-ribose) forms a high affinity complex with ASF/SF2 thereby leaving topoisomerase I available for directing its action onto DNA. We identified two functionally important domains, RRM1 and RS, as specific poly(ADP-ribose) binding targets. Two independent lines of evidence emphasize the potential biological relevance of our findings: (i) in HeLa nuclear extracts, ASF/SF2, but not histone, phosphorylation was inhibited by poly(ADP-ribose); (ii) an in silico study based on gene expression profiling data revealed an increased incidence of alternative splicing within a subset of inflammatory response genes that are dysregulated in cells lacking a functional poly(ADP-ribose) polymerase-1. We propose that poly(ADP-ribose) targeting of topoisomerase I and ASF/SF2 functions may participate in the regulation of gene expression.

Highlights

  • Formation of a DNA1⁄7topo I complex with the enzyme being covalently bound to the 3Ј-end of the cleaved DNA strand through a tyrosine-phosphate ester bond

  • In addition to relaxing supercoiled DNA, human topoisomerase I (topo I) plays a major role in pre-mRNA splicing, being endowed with a protein kinase activity targeted at a group of splicing factors of the serine-arginine (SR)-rich protein family [6]

  • Protein targeting by PAR polymerases (PARPs)-bound polymers via non-covalent, yet specific interactions, is emerging as an important regulatory mechanism for diverse biological functions, including transcription, DNA damage signaling and checkpoint activation, proteasomal histone degradation, and mitotic spindle formation [22, 23]. topo I bears three PAR-binding sites localized in domains that are critical for the catalytic activity of the enzyme on DNA and for its regulation [24]

Read more

Summary

MATERIALS AND METHODS

Purified human topo I was obtained from TopoGen. This enzyme undergoes spontaneous conversion into a 70-kDa form lacking the N-terminal domain (⌬N-topo I). Reaction mixtures (15 ␮l) were assembled on ice and contained 50 mM Tris-HCl, pH 8.0, 0.1 mM EDTA, 1 mM DTT, 0.01% Triton X-100, 20 ␮M CPT, 0.2 mg/ml bovine serum albumin, 2% glycerol, human topo I (0.2– 0.27 pmol). After incubation at 37 °C for 20 min, reaction was stopped by adding concentrated Laemmli buffer; ASF/SF2 phosphorylation was visualized by autoradiography, after electrophoretic separation on 10% polyacrylamide gels (SDSPAGE). Double DNA Cleavage/Protein Phosphorylation Assay—Recombinant human topo I (0.2 pmol) and recombinant His-ASF/ SF-2 (2.8 pmol) were incubated at 37 °C for 20 min, in 50 mM Tris-HCl, pH 8.0, containing 0.1 mM EDTA, 1 mM DTT, 10 mM MgCl2, 0.01% Triton X-100, 20 ␮M CPT, 0.2 mg/ml bovine serum albumin, 2% glycerol, 32P-5Ј-end-labeled ds-oligonucleotide (0.034 pmol, 0.5–1.1 ϫ 106 dpm/pmol), ␥-[32P]ATP (1.5 pmol, 0.3 ϫ 106 dpm/pmol). Genes coding for at least one expressed alternatively spliced isoform were taken as positive and expressed as the percentage of total analyzed genes

RESULTS
DISCUSSION
Mouse liver
Mouse heart
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call